Dr. Patrick Hines chaired an education session on biomarkers and surrogate endpoints at the Foundation for Sickle Cell Disease Research (FSCDR) meeting the weekend of April 28-30th in Fort Lauderdale, FL. In addition to Dr. Hines, the session featured speakers from Pfizer, Wayne State University, Harvard, and Global Blood Therapeutics. The focus of the session was:  “Can Novel Biomarkers Clarify Sickle Cell Disease Status and Effects of Disease-Modifying Therapies? Current Challenges – Future Opportunities (http://sched.co/A8XP